World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
16823
World Ranking
12971
National Ranking
5529

Mark S. Klempner publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark S. Klempner sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 156 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mark S. Klempner D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Klempner sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 1994 - Oswald Avery Award, Infectious Diseases Society of America
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Mark S. Klempner is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular focus on Infectious Diseases, Endocrinology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Immunology.

The main research topics covered in their work include:

  • Viral gastroenteritis research and epidemiology
  • Escherichia coli research studies
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Transgenic Plants and Applications
  • COVID-19 Clinical Research Studies
  • Bacteriophages and microbial interactions

They have published multiple papers, with some recent examples being:

  • A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction, 2020, Nature Communications
  • Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design, 2021, Scientific Reports
  • Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody, 2020, ACS Biomaterials Science & Engineering
  • IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model, 2020, Vaccine

Their work has been published frequently in venues such as Scientific Reports, bioRxiv (Cold Spring Harbor Laboratory), Vaccine, Nature Communications, and ACS Biomaterials Science & Engineering.

Among frequent co-authors are:

  • Lisa A. Cavacini
  • Yang Wang
  • Monir Ejemel
  • Zachary A. Schiller
  • Aaron Wallace

Mark S. Klempner has been recognized with awards including the Oswald Avery Award from the Infectious Diseases Society of America in 1994 and is a member of the Association of American Physicians.

Best Publications

  • The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

    Gary P. Wormser;Raymond J. Dattwyler;Eugene D. Shapiro;John J. Halperin

  • The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

    S Endres;R Ghorbani;V E Kelley;K Georgilis

  • Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

    Mark S. Klempner;Linden T. Hu;Janine Evans;Christopher H. Schmid

  • Characterization of the surface enhanced raman scattering (SERS) of bacteria.

    W. R. Premasiri;D. T. Moir;M. S. Klempner;N. Krieger

  • A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent lyme disease

    L H Sigal;J M Zahradnik;P Lavin;S J Patella

  • Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134))

    G. P. Wormser;R. J. Dattwyler;E. D. Shapiro;John Halperin

  • An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein.

    Carol A. Crowley;John T. Curnutte;Richard E. Rosin;Janine André-Schwartz

  • Central nervous system disease in systemic lupus erythematosus: Therapy and prognosis

    John S. Sergent;Michael D. Lockshin;Mark S. Klempner;Benjamin A. Lipsky

  • Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

    Mark S. Klempner;Charles A. Dinarello;John I. Gallin

  • Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague.

    L E Lindler;M S Klempner;S C Straley

  • Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

    Zachary A. Bornholdt;Hannah L. Turner;Charles D. Murin;Wen Li

  • Cognitive function in post-treatment Lyme disease Do additional antibiotics help?

    R. F. Kaplan;R. P. Trevino;G. M. Johnson;L. Levy

  • Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies.

    N Dana;B Styrt;J D Griffin;R F Todd

  • An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy

    Mark S. Klempner;Richard Noring;James W. Mier;Michael B. Atkins

  • Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation.

    M S Klempner;R B Mikkelsen;D H Corfman;J André-Schwartz

  • Invasion of Human Skin Fibroblasts by the Lyme Disease Spirochete, Borrelia burgdorferi

    Mark S. Klempner;Richard Noring;Rick A. Rogers

  • Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance

    Nicole M. Vega;Kyle R. Allison;Kyle R. Allison;Amanda N. Samuels;Amanda N. Samuels;Mark S. Klempner

  • Clindamycin Uptake by Human Neutrophils

    Mark S. Klempner;Barbara Styrt

  • Separation and functional characterization of human neutrophil subpopulations

    Mark S. Klempner;John I. Gallin

  • Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils.

    K Georgilis;C Schaefer;C A Dinarello;M S Klempner

Frequent Co-Authors

Lisa A. Cavacini
Lisa A. Cavacini University of Massachusetts Chan Medical School
Allen C. Steere
Allen C. Steere Harvard University
Gary P. Wormser
Gary P. Wormser New York Medical College
Ross E. Rocklin
Ross E. Rocklin Tufts Medical Center
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
James W. Mier
James W. Mier Beth Israel Deaconess Medical Center
John I. Gallin
John I. Gallin National Institutes of Health
Christopher H. Schmid
Christopher H. Schmid Brown University
Celia A. Schiffer
Celia A. Schiffer University of Massachusetts Chan Medical School
Peter J. Krause
Peter J. Krause Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Mark S. Klempner

Trending Scientists

Recently Published Articles